Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Aug 27, 2008 3:53pm
318 Views
Post# 15414223

RE: Look at nortel....

RE: Look at nortel....

  Good to see you are still around Felco...   seems like most of our network are still on board... albeit bruised and battered.    I know most of us Westcoasters have tried to ignore the summer trading....   but its been difficult ! 

Frankly,   I agree with the your or Kev's contention that that this deal could finally be one that  surprises us on the upside.... and may change the fortunes of this company at long last.      Again,  frustratingly...  the initial announcement is vague and light on detail...   I am told that was done as a result of mandatory TSX shelf filing requirements related to the $7mm financing aspect of the deal....  I guess we will see.   

   I have to think  that the commercial value of the key plasma proteins using PLI's process should be very substantial with the right player..... especially given the commercial scale acceptance and production being done at the Fractionator level now....   which is a huge endorsement of the basic process.  

I sincerely hope this deal is with a truly  substantial industry player with good cash and existing infrastructure that can start with the process quickly and decisively.

I am hearing the week of Sept 2nd is when we will get details...   just in time for the boyz to be back from their summer frolicking.

hang in there..
Bullboard Posts